Role of anlotinib plus albumin paclitaxel regimen in stage IV non-small cell lung cancer and mental state

doi:10.5498/wjp.v15.i8.103735

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 8

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (30)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-5) series, Tables (1-1) series.

Item

Count

PDF

HTML

Figures (1-5)

Tables (1-1)

Sum=29

Aug 19, 2025 (publication date) through Aug 8, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Psychiatry

ISSN

2220-3206

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Psychiatry. Aug 19, 2025; 15(8): 103735
Published online Aug 19, 2025. doi: 10.5498/wjp.v15.i8.103735

Full Size Figure Download Figure

Figure 1 Serum marker levels. A: Carcinoembryonic antigen; B: Cytokeratin 19 fragment antigen 21-1; C: Vascular endothelial growth factor. ^aP < 0.05 vs pre-treatment, ^bP < 0.05 vs conventional therapy. CEA: Carcinoembryonic antigen; Cyfra21-1: Cytokeratin 19 fragment antigen 21-1; VEGF: Vascular endothelial growth factor.

Citation: Zhang W, Zhao YF, Liang FF, Liu XX, Liu JH, Hao JD, Cheng SQ, Wu YF. Role of anlotinib plus albumin paclitaxel regimen in stage IV non-small cell lung cancer and mental state. World J Psychiatry 2025; 15(8): 103735
URL: https://www.wjgnet.com/2220-3206/full/v15/i8/103735.htm
DOI: https://dx.doi.org/10.5498/wjp.v15.i8.103735